Novo CEO pressed by Senate to chop price ranges of obesity, diabetic issues drugs CEO Lars Fruergaard Jørgensen advised lawmakers the business would consider new talks with insurers about the checklist selling prices of Wegovy and copyright whenever they pledge to maintain the medicines on their own formularies. Elevance lowers https://label-the-figure-with-the92468.dbblog.net/3940239/about-healthcare-news